Fairmount Funds Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-953,396
| Closed | -$30.5M | – | 27 |
|
|
2022
Q2 | $30.5M | Sell |
953,396
-228,911
| -19% | -$7.31M | 6.97% | 4 |
|
|
2022
Q1 | $41M | Buy |
1,182,307
+439,307
| +59% | +$15.2M | 9.68% | 2 |
|
|
2021
Q4 | $21.7M | Buy |
743,000
+493,000
| +197% | +$14.4M | 7.17% | 5 |
|
|
2021
Q3 | $6.37M | Buy |
250,000
+40,000
| +19% | +$1.02M | 2.32% | 17 |
|
|
2021
Q2 | $7.35M | Buy |
210,000
+35,000
| +20% | +$1.23M | 3.02% | 16 |
|
|
2021
Q1 | $7.13M | Sell |
175,000
-40,000
| -19% | -$1.63M | 3.01% | 16 |
|
|
2020
Q4 | $9.31M | Buy |
+215,000
| New | +$9.31M | 3.33% | 13 |
|